碳酸酶抑制剂和激活剂的药物相互作用
1Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, FI, Italy.
Expert opinion on drug metabolism & toxicology
|March 7, 2024
概括
碳酸胺酶抑制剂和激活剂表现出多种药物相互作用. 组合提供了对心力衰竭,眼睛疾病,感染,肥胖,帕金森病和癌症的新治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 碳酸无水酶 (CA) 是已确立的药物点,有大量临床使用的抑制剂 (硫胺/硫酸盐) 用于各种疾病.
- 抗CA抑制剂被用作利尿剂,抗白血病,抗和抗肥胖剂.
- 一种CA抑制剂衍生物SLC-0111正在临床试验中,用于抗瘤/抗转移应用.
研究的目的:
- 审查涉及碳酸酶抑制剂和激活剂的药物相互作用.
- 突出这些药物组合产生的新型治疗应用.
- 涵盖2020年3月至2024年1月期间出版的文献.
主要方法:
- 关于涉及CA抑制剂和激活剂的药物相互作用的文献综述.
- 分析报告的治疗结果和协同效应.
- 对药理学活动和临床应用的研究结果的综合.
主要成果:
- 乙醇胺与循环利尿剂相结合,对急性不补偿性心力衰竭有效.
- 像乙醇胺与贝瓦齐祖马布或NSAIDs这样的组合治疗眼睛疾病.
- 当与其他化疗药物相结合时,CA抑制剂表现出对各种病原体的抗感染特性和协同作用的抗瘤作用.
结论:
- 涉及碳酸酶抑制剂的药物相互作用揭示了超出其主要指示的显著治疗潜力.
- 涉及CA抑制剂的组合疗法为管理复杂疾病提供了有希望的策略,包括感染和癌症.
- 鉴于有限的临床数据,对CA激活剂相互作用的进一步研究是有必要的.
更多相关视频
08:21A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
4.8K
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
12.7K
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
636
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
636
01:25Antihypertensive Drugs: Direct Renin Inhibitors
625
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
625
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
730
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
730
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
545
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
545
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
632
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
632